We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Cintas
CTAS
$81.1B
| $147M | 0.21% |
1,302,800
-211,652
| -14% | -$22.9M |
|
127
Dollar Tree
DLTR
$24.9B
| $143M | 0.2% |
1,013,630
+305,977
| +43% | +$45.5M |
|
128
Tenaris
TS
$27.4B
| $143M | 0.2% |
4,055,896
+947,995
| +31% | +$30.3M |
|
129
Cognizant
CTSH
$26.3B
| $141M | 0.2% |
2,461,731
+426,331
| +21% | +$25M |
|
130
Johnson & Johnson
JNJ
$631B
| $141M | 0.2% |
795,704
+702,949
| +758% | +$121M |
|
131
LKQ Corp
LKQ
$6.22B
| $140M | 0.2% |
2,619,788
-134,540
| -5% | -$7.11M |
|
132
Enphase Energy
ENPH
$5.41B
| $140M | 0.2% |
527,745
+326,975
| +163% | +$95.1M |
|
133
United Airlines
UAL
$40.2B
| $139M | 0.2% |
3,695,977
+3,480,233
| +1,613% | +$141M |
|
134
Infosys
INFY
$50.9B
| $128M | 0.18% |
7,130,565
+1,111,022
| +18% | +$20.7M |
|
135
Starbucks
SBUX
$119B
| $128M | 0.18% |
1,285,700
+1,018,592
| +381% | +$96.1M |
|
136
Biogen
BIIB
$30.6B
| $124M | 0.17% |
446,799
-183,697
| -29% | -$51.9M |
|
137
Barclays
BCS
$94.3B
| $123M | 0.17% |
15,760,226
+4,013,456
| +34% | +$29.3M |
|
138
PBF Energy
PBF
$7.86B
| $123M | 0.17% |
3,004,478
+931,301
| +45% | +$38.7M |
|
139
Keurig Dr Pepper
KDP
$39.9B
| $122M | 0.17% |
3,434,010
+1,515,061
| +79% | +$56.8M |
|
140
Datadog
DDOG
$93.6B
| $122M | 0.17% |
1,664,614
-675,231
| -29% | -$52.7M |
|
141
Capri Holdings
CPRI
$1.75B
| $122M | 0.17% |
2,125,477
-93,583
| -4% | -$4.73M |
|
142
AutoNation
AN
$6.88B
| $120M | 0.17% |
1,116,255
+414,240
| +59% | +$45.8M |
|
143
Norfolk Southern
NSC
$75B
| $119M | 0.17% |
483,834
+36,763
| +8% | +$8.7M |
|
144
Waters Corp
WAT
$40.4B
| $118M | 0.17% |
345,119
+33,614
| +11% | +$10.6M |
|
145
AB InBev
BUD
$164B
| $115M | 0.16% |
1,910,667
-436,863
| -19% | -$23.5M |
|
146
ArcelorMittal
MT
$55.7B
| $113M | 0.16% |
4,311,990
+3,975,289
| +1,181% | +$97.5M |
|
147
Lumen
LUMN
$6.85B
| $112M | 0.16% |
21,507,098
+15,989,152
| +290% | +$98.3M |
|
148
Akamai
AKAM
$16.9B
| $110M | 0.15% |
1,310,113
+599,089
| +84% | +$52.2M |
|
149
British American Tobacco
BTI
$123B
| $110M | 0.15% |
2,744,337
-443,573
| -14% | -$17.4M |
|
150
Idexx Laboratories
IDXX
$46.9B
| $110M | 0.15% |
268,688
+5,576
| +2% | +$2.16M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.